Bixia Tang

Phase II Randomized Trial Comparing High-Dose IFN-α2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

Bin Lian, Lu Si, Chuanliang Cui et al. · Clinical Cancer Research · 2013 · 200 citations

Medicine, Oncology, Surgery +17

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients

Bixia Tang, Xieqiao Yan, Xinan Sheng et al. · Journal of Hematology & Oncology · 2019 · 188 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

Xue Bai, Jiani Hu, Allison Betof Warner et al. · Clinical Cancer Research · 2021 · 176 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G₄ Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial

Xinan Sheng, Xieqiao Yan, Zhihong Chi et al. · Journal of Clinical Oncology · 2019 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy

Yan Kong, Xinan Sheng, Xiaowen Wu et al. · Clinical Cancer Research · 2017 · 116 citations

Medicine, Molecular Genetics, Oncology +17